Literature DB >> 7252832

Mesophase formation during in vitro cholesterol gallstone dissolution: a specific effect of ursodeoxycholic acid.

C C Su, J Y Park, W I Higuchi, M H Alkan, O I Corrigan, A F Hofmann, R G Danzinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7252832     DOI： 10.1002/jps.2600700644

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  5 in total

1.  Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients.

Authors:  A Colecchia; G Mazzella; L Sandri; F Azzaroli; M Magliuolo; P Simoni; M L Bacchi-Reggiani; E Roda; D Festi
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

2.  Cholesterol (thermodynamic) activity determinations in bile salt-lecithin-cholesterol systems and cholesterol-rich liquid crystalline mesophase formation.

Authors:  U K Jain; W I Higuchi; C L Liu; P H Lee; N A Mazer
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

Review 3.  Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

4.  Mixed micelles as proliposomes for the solubilization of teniposide.

Authors:  H Alkan-Onyuksel; K Son
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

5.  A mixed micellar formulation suitable for the parenteral administration of taxol.

Authors:  H Alkan-Onyuksel; S Ramakrishnan; H B Chai; J M Pezzuto
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.